Transmembrane helical proteins are underrepresented in the PDB due to the experimental difficulties associated with their protein expression and crystallisation. This results in a small pool of structures being available for conventional homology-based Molecular Replacement (MR) and places a premium on the development of unconventional homology-independent approaches. AMPLE is a pipeline for using unconventional models in automated MR. It has been particularly successful in its cluster-andtruncate approach to creating ensemble search models from ab initio molecular models for globular targets [1]. Recent work has focussed on exploring the viability of AMPLE's approach to transmembrane protein targets. By sampling multiple clusters of ab initio models and using new scoring algorithms, we have been able to double the success rate of AMPLE on a difficult set of test cases without an increase in processing time. Additionally, exploring new bioinformatics approaches, such as restraining ab initio structure prediction using predicted residue-residue contacts, has pushed the boundaries of AMPLE's success [2].
